This reference summarizes information about pharmaceuticals that can target infectious strains of coronaviruses to neutralize infections. Chapters focus on SARS-CoV-2, drug discovery methods and natural methods to combat the virus, which is a causative agent of COVID-19.
Specifically, the book presents 5 chapters written by expert scholar on the following topics:
Structure-Based Drug Discovery Approaches Applied to SARS-CoV-2 (the causative agent COVID- 19)
Potential Antiviral Medicinal Plants against Novel SARS-CoV-2
Infections Caused by SARS Coronaviruses: Main Characteristics, Targets and Inhibitors
Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID- 19
Peptidomimetic and Peptide-Derived Agents Against 3CLpro from Coronaviruses
The book contents present both conventional drug design and traditional approaches to discovering relevant drugs in an easy-to-read approach, which is supplemented by bibliographic references. It is intended as a reference for students (pharmacology, pharmacy) and researchers (virology) who are seeking information about antiviral drugs that can be used against coronaviruses.
Audience: Students and researchers in the field of pharmacology and pharmacy; biochemists and virologists.